Weil Gotshal & Manges and Slaughter and May have scooped key mandates on Bain Capital’s proposed £1.2bn takeover of UK insurer esure as RPC and Clifford Chance (CC) wade into the House of Fraser saga.
Weil is advising Bain on the proposed take-private, which will see the private equity player acquire, via its Blue (BC) Bidco Limited subsidiary, all shares in the motor and home insurer for 280 pence per share. The Weil team is led by private equity partner Marco Compagnoni and senior consultant Ian Hamilton. Continue reading “Deal watch: Weil and Slaughters lead on Bain’s £1.2bn esure bid as CC and RPC land House of Fraser roles”
The global M&A market is booming. Bill Mordan, general counsel at FTSE 100 drug-maker Shire, would know. Shire’s board recently recommended a £46bn takeover offer from rival Japanese pharma giant Takeda.
‘Money continues to be cheap to borrow and so it’s still easy to get funding from venture capital, as well as other speciality equity investments in new technologies,’ Mordan comments. ‘There’s a large quantum of assets out there available for acquisition.’ Continue reading “Big deals – meet the GCs running the headline deals”
In a deal of major national significance, Holman Fenwick Willan (HFW) and Clifford Chance (CC) have advised the Greek state on the €535m privatisation of its gas network. Meanwhile US leaders Kirkland & Ellis, Weil Gotshal & Manges and Jones Day have also acted on substantial buyouts recently.
The sale of the natural gas transmission system operator, DESFA, is part of Greece’s wider strategy of disposing assets to reduce the country’s debt following the financial crisis. The deal implies a total equity value for DESFA of €810m. Continue reading “Deal watch: HFW acts for Greek government on major state sell-off while US firms score heavyweight mandates”
Marco Cillario sizes up the pros and cons for legal advisers of the current ICO boom
‘We are in an odd position: we feel we need to be closely involved in this, but there is a reputational risk because there is a lot of fraud.’ Understandably, the partner expressing this view does not want himself or his firm identified. But such words still sum up many securities lawyers’ feelings on the hottest topic in their field for years. Continue reading “Focus: Wild West or new frontier? Securities counsel divided as the cryptocurrency ‘float’ rears its blockchained head”
Life sciences giant puts £46bn offer on table for Irish rival
Magic Circle duo Slaughter and May and Linklaters have been joined by Davis Polk & Wardwell and Ashurst in landing key mandates as Japanese giant Takeda Pharmaceutical Company launched a £46bn takeover of Shire last month. Continue reading “Global elite joins Japanese and offshore heavyweights as Takeda persists with Shire bid”
Ten years after acquiring Pret A Manger in a deal worth £350m, private equity house Bridgepoint is selling it for more than four times its original investment and providing City firms with big mandates.
Luxembourg-headquartered JAB Holding Company, an investment firm owned by Germany’s Reimann family, is to buy the food chain for £1.5bn. Continue reading “Rich pickings for Travers Smith and Freshfields as Bridgepoint cashes in on Pret”
‘Theirs is the biggest succession issue faced by any firm in the City,’ says one Magic Circle partner of Skadden, Arps, Slate, Meagher & Flom’s prospects, following the retirement of veteran dealmaker Michael Hatchard (pictured right) at the end of last year.
The widely-admired Hatchard did much to make Skadden a US trailblazer in public M&A work in Europe. Though leveraged finance hogs the headlines these days, Hatchard and Skadden were still the competitive forces most cited by top M&A partners at London rivals. Having moved from Theodore Goddard in 1994, Hatchard (who remains a consultant to Skadden) was one of the most successful transfers ever in City law. Continue reading “Deal View: Life after Hatchard – does Skadden hunger to take its peerless M&A team to the next level?”
Within the same week, two Magic Circle firms stressed to Legal Business the same mantra after departures of big-name lawyers: it is not about stars, the focus is the platform and that is what top clients are buying. In a mobile market where even the once-untouchable elite City law firms lose marquee names to high-paying rivals, it is an increasingly familiar refrain, albeit one that has spread from mid-weight stalwarts to the tier more used to the role of hunter than prey.
But law firms – and this goes double for the leaders in the UK and US – would be well advised to go nowhere near the seductive institutional defence and not only because the financial results of the last ten years provide ample evidence that contradicts the assertion. Continue reading “Comment: Star power is core to the law firm sales pitch – clients won’t buy excuses”
Paul Hastings has hired Anu Balasubramanian to lead its private equity team in London, a striking move that sees DLA Piper lose one of its brightest deal stars.
The loss of Balasubramanian will be a fresh blow for DLA after a turbulent few months that have seen a high-profile partner exodus in the City to McDermott Will & Emery (MWE). Continue reading “Another City loss for DLA Piper as private equity star quits for Paul Hastings”
Marco Cillario finds much more substance to CC’s PE business than the usual critique but stopping managed relative decline will only get harder
‘Look at the team they had in the mid-2000s: strong personalities, industry leaders, primary advisers to any significant private equity house. There has never been a team that strong in Europe. They failed to bring through any meaningful succession.’ Continue reading “Reports of the death of CC’s sponsor practice prove exaggerated but surviving isn’t thriving”